Novavax (NVAX) 2020 Q4 Earnings Results
Novavax Inc. (NASDAQ:NVAX) has been around for more than 33 years now. However, the biotech company has so far struggled to develop an approved vaccine in its decades-long history.
Novavax Inc (NVAX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
5 Fastest Growing Biotech Companies in the US
In this article we discuss the 5 Fastest Growing Biotech Companies in the US.
Wednesday’s Hot Stocks in Focus
Microvision Inc. (NASDAQ:MVIS) shares plummeted more than 26 percent this morning apparently after a series of tweets and retweets from short-seller Hindenburg Research on Tuesday.
Is NVAX A Good Stock To Buy According To Hedge Funds?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Funds Are Piling Into Novavax, Inc. (NVAX)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Fund and Insider Trading News: Whale Rock Capital Management, Marble Ridge Capital LP, Delbrook Capital, RealPage Inc (RP), Procter & Gamble Co (PG), and More
After taking large positions on work-from-home stocks early this year, Alex Sacerdote’s Whale Rock Capital Management made a new bet on a payments company and dumped some blue-chip stocks in the second...
Is Novavax, Inc. (NVAX) A Good Stock To Buy?
In this article we will check out the progression of hedge fund sentiment towards Novavax, Inc. (NASDAQ:NVAX) and determine whether it is a good investment right now.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016.
Should You Buy Novavax, Inc. (NVAX)?
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible ramifications of rising...
Here's What Hedge Funds Think About Novavax, Inc. (NVAX)
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
